Immuno-Oncology & Biomarker Summit 2026

The Immuno-Oncology & Biomarker Summit 2026 presents innovation in immuno-oncology and biomarker science through next-generation therapies, precision diagnostics, and translational strategies.

Key Topics

• Next-generation immunotherapies
• Cellular therapies
• Antibody-drug conjugates (ADCs)
• Bispecific antibodies
• Immune checkpoint inhibitors
• Combination strategies
• Pre-clinical research
• Translational approaches
• Personalized immunotherapy evolution
• Biomarker discovery
• Immune monitoring
• Vaccine development
• Multi-omic integration
• Cancer vaccines
• Oncolytic viruses

Who should Attend

• Immuno-oncology professionals
• Biomarker specialists
• Cell therapy experts
• Antibody developers
• Translational researchers
• Diagnostics professionals
• Precision medicine teams
• Clinical trial professionals
• Drug development teams
• Commercialization professionals
• Cancer vaccine researchers
• Oncolytic virus specialists
• Genomics professionals
• Bioinformatics experts
• Investors
• CEOs
• CSOs
• Presidents
• Vice Presidents
• Executive Directors
• Associate/Senior Directors
• Managers/Senior Managers
• Department heads